Related Experiment Video
Updated: Mar 18, 2026

08:09
Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
Published on: December 13, 2019
23.2K
Epinephrine and left atrial and left ventricular diastolic function decrease in normal subjects.
Abdel J Fuenmayor1, Moisés I Solórzano1, Luisangelly Gómez1
1Cardiovascular Research Institute "Abdel M. Fuenmayor P", University Hospital of The Andes, Mérida, Venezuela.
International Journal of Cardiology
|July 9, 2016
Summary
Epinephrine infusion in young adults without heart disease is safe. It caused minor decreases in left atrial and left ventricular diastolic function, affecting heart performance.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Assessing the impact of epinephrine on cardiac function in healthy individuals.
- Focus on left atrial and left ventricular diastolic function.
Purpose of the Study:
- To evaluate the effects of epinephrine on diastolic function in subjects without structural heart disease.
- To determine the safety and functional impact of epinephrine administration.
Main Methods:
- Echocardiography used to assess left atrial and ventricular function.
- Intravenous epinephrine infusion administered at 50-100 ng/kg/min.
- Evaluations conducted before and during epinephrine infusion in 27 participants.
Main Results:
- Epinephrine infusion was safe with no observed complications.
- Significant increases in heart rate and systolic blood pressure noted.
- Left atrial function showed decreased expansion index and ejection fraction; left ventricular diastolic function parameters (E/A, e') decreased, and isovolumetric relaxation time increased.
Conclusions:
- Epinephrine infusion is safe in young adults without structural heart disease.
- A small but significant decrease in left atrial and left ventricular diastolic function was observed.
- Epinephrine administration can alter diastolic function parameters even in healthy individuals.
Related Concept Videos
Heart Failure II: Pathophysiology
1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Hormonal Regulation of Blood Pressure
7.1K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.1K
Heart Failure Drugs: β-Blockers
1.1K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K

